SCHEMBL21064799

SCHEMBL21064799

N[C@H](Cc1cncs1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.47
CYP3A4 P08684 2/20 0.47
SLC1A3 P43003 1/20 0.46
HSD17B10 Q99714 2/20 0.44
PKM P14618 2/20 0.43
ALPI P09923 1/20 0.43
PTGS1 P23219 1/20 0.43
XIAP P98170 1/20 0.43
CTSC P53634 1/20 0.42
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
GRIA2 P42262 3/20 0.41
GRIA1 P42261 2/20 0.41
GRIA3 P42263 2/20 0.41
GRIA4 P48058 2/20 0.41
SLC6A3 Q01959 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
USP2 O75604 2/20 0.40
RGS12 O14924 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2727898 1.00 SLC7A5 (0.47) SLC7A5CYP3A4SLC1A3HSD17B10PKM
SCHEMBL2727900 1.00 SLC7A5 (0.47) SLC7A5CYP3A4SLC1A3HSD17B10PKM
SCHEMBL3659943 0.75 PARP15 (0.44) CTSCPARP15PARP10SLC6A3TDP1
SCHEMBL6193383 0.74 PARP15 (0.36) CTSCPARP15PARP10SLC6A3TDP1
SCHEMBL6193388 0.74 PARP15 (0.36) CTSCPARP15PARP10SLC6A3TDP1
SCHEMBL9480 0.74 PARP15 (0.43) PARP15PARP10SLC6A3TDP1LMNA
SCHEMBL16160203 0.74 CHRM1 (0.41) CYP3A4HSD17B10CTSC
SCHEMBL9727913 0.73 SLC6A3 (0.38) CTSCPARP15PARP10SLC6A3
SCHEMBL6652600 0.73 SLC6A3 (0.38) PARP15PARP10SLC6A3TDP1LMNA
SCHEMBL6652598 0.73 SLC6A3 (0.38) CTSCPARP15PARP10SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329321-B2 Site-selective functionalization of proteins using traceless affinity labels Krantz, Alexander (US) 2019-06-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329321-B2 Site-selective functionalization of proteins using traceless affinity labels MYCBP, FABP3, STUB1 SLC7A5 955/4885CYP3A4 3090/4885SLC1A3 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.